Tech Company Financing Transactions
Permeon Biologics Funding Round
Flagship Pioneering and private investors invested in a $2.5 million funding round for Permeon Biologics. The round closed on 12/30/2011.
Transaction Overview
Company Name
Announced On
12/30/2011
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$2,500,600
Round
Undisclosed
Investors
Flagship Pioneering (Noubar Afeyan)
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Kendall Sq. 1400W - 14203
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Permeon brings together visionary scientists and proven leadership to drive innovation in therapeutic drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Ripple
Browse more venture capital transactions:
Prev: 12/30/2011: Scope 5 venture capital transaction
Next: 12/30/2011: AllTrails venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs